©The Author(s) 2026.
World J Gastroenterol. Jan 7, 2026; 32(1): 112496
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.112496
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.112496
Table 2 Different genetic pathway disorders, its mechanism of action in gastrointestinal tract
| Genetic pathway disorder | Mechanism | Examples |
| Monogenic disorders | Mutations in a single gene that often follow Mendelian inheritance patterns | Hereditary hemochromatosis (HFE gene), Wilson disease (ATP7B gene), alpha-1 antitrypsin deficiency |
| Polygenic and multifactorial disorders | Involve multiple genes and environmental interactions | Inflammatory bowel disease (over 200 loci have been identified), celiac disease (HLA-DQ2 and HLA-DQ8) |
| Cancer predisposition syndromes | Inherited mutations in tumor suppressor genes or DNA repair genes increase GI cancer risk | Lynch syndrome (HNPCC) (MLH1, MSH2), familial adenomatous polyposis (APC) gene |
| Mosaicism | Two or more genetically distinct cell populations within the same individual, derived from a single zygote | Mosaic APC gene mutations may cause attenuated forms of FAP. Very early changes in IBD |
- Citation: Kumar A, Sarangi Y, Kaw P. Gene, genetics and genetic medicines in gastroenterology: Current status and its future. World J Gastroenterol 2026; 32(1): 112496
- URL: https://www.wjgnet.com/1007-9327/full/v32/i1/112496.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i1.112496